Radeberg, Germany Clinical Trials

A listing of Radeberg, Germany clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 72 clinical trials
Dose-ranging Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

This study evaluates the efficacy of orally administered PHA-022121 for the acute treatment of attacks in patients with hereditary angioedema (HAE). Eligible subjects are randomized to one of three single doses of PHA-022121 and placebo. The study will compare symptom relief (skin pain, skin swelling, abdominal pain) during HAE attacks …

Study site
 (8.8 away) Contact site
  • 22 Sep, 2021
  • +26 other locations
A Study to Investigate the Use of Benralizumab in Patients With Chronic Spontaneous Urticaria Who Are Symptomatic Despite the Use of Antihistamines (ARROYO)

The purpose of this study is to investigate the use of benralizumab is effective in the treatment of chronic spontaneous urticaria (CSU) who are symptomatic despite the use of antihistamines.

Research site
 (9.3 away) Contact site
  • 19 Sep, 2021
  • +36 other locations
A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight

This study is open to adults, aged 18 to 75 years, with overweight or obesity. People with body mass index (BMI) of 27 or higher to join the study. People who have diabetes cannot participate. The purpose of this study is to find out whether a medicine called BI 456906 …

body mass index
overweight or obesity
Universit tsklinikum Carl Gustav Carus Dresden
 (7.4 away) Contact site
  • 15 Sep, 2021
  • +47 other locations
Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria

The primary objective of this study is to evaluate the effect of tezepelumab on improvement in the Urticaria Activity Score over 7 days (UAS7).

Universitaetsklinikum Dresden
 (7.4 away) Contact site
  • 10 Sep, 2021
  • +73 other locations
Study to Evaluate the Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)

The primary objective is to evaluate the efficacy of brexucabtagene autoleucel (KTE-X19) in participants with relapsed/refractory (r/r) mantle cell lymphoma (MCL) in Cohort 3 of this study.

Universit tsklinik Dresden
 (8.8 away) Contact site
  • 20 Aug, 2021
  • +32 other locations
Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19

The purpose of the study is to assess the safety and efficacy of ATR-002 (in addition to standard-of-care) for the treatment of COVID-19

Atriva study site 49011
 (8.8 away) Contact site
  • 10 Jul, 2021
  • +30 other locations
Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter Randomized Phase II Trial of the German Anal Cancer Study Group

The RADIANCE multicenter, randomized phase II trial will assess the efficacy of durvalumab, a PD-L1 immune checkpoint inhibitor, in combination with primary mitomycin C (MMC)/5-fluorouracil (5-FU)-based radiochemotherapy (RCT) in patients with locally-advanced anal squamous cell carcinoma (ASCC).

pelvic mri
antiretroviral therapy
platelet count
Klinik und Poliklinik f r Strahlentherapie und Radioonkologie
 (7.4 away) Contact site
  • 04 Jul, 2021
  • +39 other locations
Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors

Evaluation of the efficacy of the combination of olaparib and trabectedin in adult patients with locally advanced/metastatic solid tumors that failed standard treatment and whose molecular sequencing tumor profiles show homologous recombination repair (HRR) defects. The primary objective is to show superior disease control rate in patients with HRR-deficient tumors …

Medizinische Fakult t der TU Dresden
 (7.4 away) Contact site
  • 07 May, 2021
  • +8 other locations
Frontline Asciminib Combination in Chronic Phase CML

Adult male and female patients with newly diagnosed Philadelphia chromosome positive (Ph+) and/or BCR-ABL1 positive CML can be included in the study until 3 months after diagnosis. A <4 week pretreatment with hydroxyurea is permitted. Patients treated for <6 weeks with nilotinib 300 mg BID, imatinib 400 mg QD, or …

chronic phase chronic myeloid leukemia
dasatinib 100 mg
 (7.4 away) Contact site
  • 25 Aug, 2021
  • +36 other locations
Efficacy and Safety of Zanubrutinib Plus Tislelizumab for Treatment of Patients With Richter Transformation

The aim of the CLL-RT1 trial is to evaluate the efficacy and safety of zanubrutinib (BGB-3111), a BTK inhibitor plus tislelizumab (BGB-A317), a PD1 inhibitor for treatment of patients with Richter Transformation

Universit tsklinikum Carl Gustav Carus
 (7.4 away) Contact site
  • 15 Feb, 2021
  • +11 other locations